Wonderful lipid reduction in this case study.

Why These Markers Matter

ApoB — the best single measure of atherogenic particle burden (each LDL, VLDL, etc. particle carries one ApoB). Lower levels (<60–80 mg/dL on treatment) strongly correlate with slower plaque progression and lower CV event risk.

LDL-P — particle number; high counts predict events better than cholesterol mass alone because more particles can enter artery walls. Optimal on therapy is typically <1000 nmol/L.

hsCRP — marker of systemic inflammation; levels >2 mg/L signal higher plaque instability and CV risk.

Lp-PLA2 — plaque-specific inflammatory enzyme carried on LDL; elevated activity marks rupture-prone lesions and independently predicts MI and stroke.

Triglycerides & small LDL-P — high TG promotes remnant particles and inflammation; small, dense LDL is more atherogenic, though particle number trumps size when ApoB/LDL-P is low.

How the Medications Achieved This: Rosuvastatin (potent statin) blocks HMG-CoA reductase in the liver, reducing cholesterol synthesis. This upregulates LDL receptors, which clear ApoB-containing particles from blood. Result: large drops in LDL-C, ApoB, LDL-P, and small LDL-P, plus anti-inflammatory effects from less oxidized LDL and fewer atherogenic particles. It also lowers Lp-PLA2 by reducing the LDL carriers that transport the enzyme.

Icosapent ethyl (purified EPA) reduces hepatic VLDL/triglyceride production, stabilizes cell membranes, and exerts direct anti-inflammatory actions (inhibits NF-κB, lowers cytokines and oxidized lipids). It cuts TG-rich remnants, Lp-PLA2 activity, and hsCRP, often without raising LDL-C, providing additive benefit on top of statin therapy.

Synergy & Outcome

The statin drives the massive reduction in atherogenic particle number (ApoB/LDL-P), while IPE enhances control of triglycerides and inflammation (hsCRP, Lp-PLA2).

Together they yield very low residual risk on these markers—far better than statin alone in many high-risk patients. Lifestyle factors likely helped, but the medications are the primary drivers of these dramatic, favorable shifts.